Literature DB >> 29314474

Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor.

Noureldin Saleh1, Oliver Hucke2, Gert Kramer3, Esther Schmidt4, Florian Montel2, Radoslaw Lipinski2, Boris Ferger3, Timothy Clark5, Peter W Hildebrand1,6, Christofer S Tautermann2.   

Abstract

The cannabinoid CB1 receptor (CB1R) is an abundant metabotropic G-protein-coupled receptor that has been difficult to address therapeutically because of CNS side effects exerted by orthosteric drug candidates. Recent efforts have focused on developing allosteric modulators that target CB1R. Compounds from the recently discovered class of mixed agonistic and positive allosteric modulators (Ago-PAMs) based on 2-phenylindoles have shown promising functional and binding properties as CB1R ligands. Here, we identify binding modes of both the CP 55,940 agonist and GAT228, a 2-phenylindole allosteric modulator, by using our metadynamics simulation protocol, and quantify their affinity and cooperativity by atomistic simulations. We demonstrate the involvement of multiple adjunct binding sites in the Ago-PAM characteristics of the 2-phenylindole modulators and explain their ability to compete with orthosteric agonists at higher concentrations. We validate these results experimentally by showing the contribution of multiple sites on the allosteric binding of ZCZ011, another homologous member of the class, together with the orthosteric agonist.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  G-protein-coupled receptors; allostery; cannabinoid receptors; metadynamics

Mesh:

Substances:

Year:  2018        PMID: 29314474     DOI: 10.1002/anie.201708764

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  16 in total

1.  Ligand binding free-energy calculations with funnel metadynamics.

Authors:  Stefano Raniolo; Vittorio Limongelli
Journal:  Nat Protoc       Date:  2020-08-19       Impact factor: 13.491

2.  Binding of histamine to the H1 receptor-a molecular dynamics study.

Authors:  Christian A Söldner; Anselm H C Horn; Heinrich Sticht
Journal:  J Mol Model       Date:  2018-11-29       Impact factor: 1.810

3.  Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.

Authors:  Pankaj Pandey; Kuldeep K Roy; Robert J Doerksen
Journal:  J Biomol Struct Dyn       Date:  2019-02-05

4.  Identification of CB1 Receptor Allosteric Sites Using Force-Biased MMC Simulated Annealing and Validation by Structure-Activity Relationship Studies.

Authors:  Dow P Hurst; Sumanta Garai; Pushkar M Kulkarni; Peter C Schaffer; Patricia H Reggio; Ganesh A Thakur
Journal:  ACS Med Chem Lett       Date:  2019-07-10       Impact factor: 4.345

5.  The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.

Authors:  Julien C Dodu; Rebecca K Moncayo; M Imad Damaj; Joel E Schlosburg; Hamid I Akbarali; Lesley D O'Brien; Debra A Kendall; Zhixing Wu; Dai Lu; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2021-10-08       Impact factor: 4.402

Review 6.  Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.

Authors:  Eric A Wold; Jianping Chen; Kathryn A Cunningham; Jia Zhou
Journal:  J Med Chem       Date:  2018-08-28       Impact factor: 7.446

7.  Structural Perspective on Ancient Neuropeptide Y-like System reveals Hallmark Features for Peptide Recognition and Receptor Activation.

Authors:  Miron Mikhailowitsch Gershkovich; Victoria Elisabeth Groß; Oanh Vu; Clara Tabea Schoeder; Jens Meiler; Simone Prömel; Anette Kaiser
Journal:  J Mol Biol       Date:  2021-04-16       Impact factor: 6.151

Review 8.  Novel approaches and current challenges with targeting the endocannabinoid system.

Authors:  Paula Morales; Nadine Jagerovic
Journal:  Expert Opin Drug Discov       Date:  2020-04-27       Impact factor: 7.050

Review 9.  Insights From Molecular Dynamics Simulations of a Number of G-Protein Coupled Receptor Targets for the Treatment of Pain and Opioid Use Disorders.

Authors:  João Marcelo Lamim Ribeiro; Marta Filizola
Journal:  Front Mol Neurosci       Date:  2019-08-23       Impact factor: 5.639

10.  Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.

Authors:  Dinesh Thapa; Elizabeth A Cairns; Anna-Maria Szczesniak; Pushkar M Kulkarni; Alex J Straiker; Ganesh A Thakur; Melanie E M Kelly
Journal:  Molecules       Date:  2020-01-20       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.